FDA Inspection
Alexza Pharmaceuticals, Inc.Alexza Pharmaceuticals, Inc. – FDA Inspection, Sep 26, 2019
Record Details
This FDA Inspection record concerns Alexza Pharmaceuticals, Inc., with an inspection on September 26, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 316cd956-10ab-4ffb-937c-3b3bba844f2b
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1109014
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Alexza Pharmaceuticals, Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| December 19, 2025 | Not classified | San Francisco District Office | |
| August 1, 2025 | Not classified | San Francisco District Office | |
| December 22, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 21, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 13, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Alexza Pharmaceuticals, Inc.
- FDA Inspection 1300206 - 2025-12-19
- FDA Inspection 1281572 - 2025-08-01
- FDA Inspection 1227246 - 2023-12-22
- FDA Inspection 926541 - 2015-05-21
- FDA Inspection 866702 - 2014-02-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.